Prestige Consumer Healthcare Management

Management Kriterienprüfungen 4/4

Prestige Consumer Healthcare CEO ist Ron Lombardi , ernannt in Jun 2015, hat eine Amtszeit von 9.42 Jahren. Die jährliche Gesamtvergütung beträgt $5.76M , bestehend aus 17.4% Gehalt und 82.6% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.75% der Aktien des Unternehmens, im Wert von $30.67M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 7.3 Jahre bzw. 4.5 Jahre.

Wichtige Informationen

Ron Lombardi

Geschäftsführender

US$5.8m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts17.4%
Amtszeit als Geschäftsführer9.4yrs
Eigentum des Geschäftsführers0.8%
Durchschnittliche Amtszeit des Managements7.3yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder4.5yrs

Jüngste Management Updates

Recent updates

We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Nov 03
We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Popularity With Investors Is Under Threat From Overpricing

Sep 10
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Popularity With Investors Is Under Threat From Overpricing

Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Jul 16
Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Revenues Not Telling The Story For Prestige Consumer Healthcare Inc. (NYSE:PBH)

May 22
Revenues Not Telling The Story For Prestige Consumer Healthcare Inc. (NYSE:PBH)

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Mar 26
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 50% Undervalued

Mar 05
An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 50% Undervalued

Prestige Consumer Healthcare Inc. (NYSE:PBH) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Feb 11
Prestige Consumer Healthcare Inc. (NYSE:PBH) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Shares May Have Run Too Fast Too Soon

Feb 05
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Shares May Have Run Too Fast Too Soon

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Dec 14
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Sep 10
Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Prestige Consumer Healthcare: Unproductive Buyback And Excessive Valuation

Aug 15

Is Prestige Consumer Healthcare (NYSE:PBH) Using Too Much Debt?

Jun 12
Is Prestige Consumer Healthcare (NYSE:PBH) Using Too Much Debt?

An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 43% Undervalued

May 20
An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 43% Undervalued

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has Caught The Eye Of Investors

Mar 17
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has Caught The Eye Of Investors

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Mar 02
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Intrinsic Value Is Potentially 75% Above Its Share Price

Feb 08
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Intrinsic Value Is Potentially 75% Above Its Share Price

Prestige Consumer Healthcare reports Q3 earnings beat; updates FY23 guidance

Feb 02

Prestige Consumer Healthcare: Taking My Winnings Off The Table

Jan 19

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Nov 23
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Prestige Consumer Healthcare GAAP EPS of $1.02 beats by $0.02, revenue of $289.3M beats by $6.07M

Nov 03

Holding Prestige Consumer Healthcare

Aug 31

If EPS Growth Is Important To You, Prestige Consumer Healthcare (NYSE:PBH) Presents An Opportunity

Aug 26
If EPS Growth Is Important To You, Prestige Consumer Healthcare (NYSE:PBH) Presents An Opportunity

We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Aug 05
We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Prestige Consumer Healthcare GAAP EPS of $1.09 beats by $0.05, revenue of $277.1M beats by $8.18M

Aug 04

Should You Be Adding Prestige Consumer Healthcare (NYSE:PBH) To Your Watchlist Today?

May 27
Should You Be Adding Prestige Consumer Healthcare (NYSE:PBH) To Your Watchlist Today?

Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

May 05
Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

Does Prestige Consumer Healthcare (NYSE:PBH) Deserve A Spot On Your Watchlist?

Feb 22
Does Prestige Consumer Healthcare (NYSE:PBH) Deserve A Spot On Your Watchlist?

Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

Feb 03
Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Extensively

Nov 04
These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Extensively

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has A Meaningful Debt Burden

Aug 06
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has A Meaningful Debt Burden

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Ron Lombardi im Vergleich zu den Einnahmen von Prestige Consumer Healthcare verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Sep 30 2024n/an/a

US$206m

Jun 30 2024n/an/a

US$205m

Mar 31 2024US$6mUS$1m

US$209m

Dec 31 2023n/an/a

-US$81m

Sep 30 2023n/an/a

-US$82m

Jun 30 2023n/an/a

-US$84m

Mar 31 2023US$6mUS$1m

-US$82m

Dec 31 2022n/an/a

US$210m

Sep 30 2022n/an/a

US$209m

Jun 30 2022n/an/a

US$203m

Mar 31 2022US$6mUS$937k

US$205m

Dec 31 2021n/an/a

US$189m

Sep 30 2021n/an/a

US$179m

Jun 30 2021n/an/a

US$179m

Mar 31 2021US$5mUS$888k

US$165m

Dec 31 2020n/an/a

US$166m

Sep 30 2020n/an/a

US$163m

Jun 30 2020n/an/a

US$152m

Mar 31 2020US$5mUS$875k

US$142m

Dec 31 2019n/an/a

-US$34m

Sep 30 2019n/an/a

-US$34m

Jun 30 2019n/an/a

-US$36m

Mar 31 2019US$4mUS$850k

-US$36m

Dec 31 2018n/an/a

US$64m

Sep 30 2018n/an/a

US$340m

Jun 30 2018n/an/a

US$340m

Mar 31 2018US$4mUS$850k

US$340m

Vergütung im Vergleich zum Markt: RonDie Gesamtvergütung ($USD5.76M) liegt im Durchschnitt der Unternehmen ähnlicher Größe auf dem Markt US ($USD6.60M).

Entschädigung vs. Einkommen: RonDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.


Geschäftsführer

Ron Lombardi (60 yo)

9.4yrs

Amtszeit

US$5,763,133

Vergütung

Mr. Ronald M. Lombardi, also known as Ron, served as a Director at Consumer Healthcare Products Association. He has been the Chief Executive Officer and President of Prestige Brands Holdings, Inc. (now Pre...


Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Ronald Lombardi
Chairman9.4yrsUS$5.76m0.75%
$ 30.7m
Christine Sacco
Chief Financial Officer8.2yrsUS$2.00m0.036%
$ 1.5m
Jeffrey Zerillo
Senior Vice President of Operations6.6yrsUS$862.93k0.064%
$ 2.6m
William P'Pool
Senior VP8yrsUS$1.34m0.026%
$ 1.1m
Adel Mekhail
Executive Vice President of Marketing & Sales5.5yrsUS$1.32m0.024%
$ 1.0m
Philip Terpolilli
Director of Investor Relationsno datakeine Datenkeine Daten
Dean Siegal
Director of Communicationsno datakeine Datenkeine Daten
Mary Fritz
Senior Vice President of Quality & Regulatory Affairs6.4yrskeine Daten0.030%
$ 1.2m

7.3yrs

Durchschnittliche Betriebszugehörigkeit

60yo

Durchschnittliches Alter

Erfahrenes Management: PBHDas Führungsteam des Unternehmens verfügt über eine langjährige Erfahrung (7.3 ).


Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Ronald Lombardi
Chairman9.4yrsUS$5.76m0.75%
$ 30.7m
John Byom
Lead Independent Director18.8yrsUS$273.33k0.097%
$ 4.0m
Clesteen Clark
Independent Director3.8yrsUS$257.08k0.014%
$ 573.9k
Dawn Zier
Independent Director4.5yrsUS$260.63k0.020%
$ 821.8k
Sheila Hopkins
Independent Director9.3yrsUS$243.33k0.048%
$ 1.9m
James D'Arecca
Independent Director1.3yrsUS$197.92kkeine Daten
John Kelly
Independent Directorless than a yearkeine Datenkeine Daten

4.5yrs

Durchschnittliche Betriebszugehörigkeit

63yo

Durchschnittliches Alter

Erfahrener Vorstand: PBHDie Vorstandsmitglieder gelten als erfahren (4.5 Jahre durchschnittliche Amtszeit).